MACD cross, other indicators primed and ready. We'll see! Last news evidence of manufacturing process
starting in one of the bigger projects. What could be a catalyst from here? Large distributor or 3rd party,
end of the clinical trials for Haemoband, Auto news. Clock is ticking.
Oh, and I am fairly certain that the 13,000 figure represents pairs of inserts and this as
noted is probably a minimum purchase order agreed upon. Looks promising
Over-Sold. Stochs oversold. Positive MACD divergence.
Probably some news update next week.
Fundamentals unchanged. Three major product launches this year, Mettis and scopes first
half, and auto ramping up. Fair value now? Almost double. 6 months from now? More. JMO.
I don't have an explanation for the drop. Any excuse when the stop drops is as good as another when
there is no news to explain it, and as far as I know, no change in the fundamentals. Every day is one
day closer to a deal, signed contract, significant announcement. Is the sky falling? Last time we went
from .30 to .125 and now .35 to .18. I feels about the same as I did back then at .125-
Oh yeah Calvin, and while you're making inquires don't forget to inquire about the auto project launching this year with top auto maker.
All Google my friend. Stock down a bit, offers up a bit, and now bashers show up. I wonder if the "smart" money is on the buy side as it has been for a few months now? Fundamentals unchanged. Haemoband will deliver. The product sounds too good and will sell itself IMO.
Speaking of Ireland. Forbes number one country for doing business with the U.S. number 14.
European headquarters for Facebook, Twitter, Google, Linked-In and Medtronic (medical) with a large
presence, just to name a few.
Here we go with the bashers. Haemoband is a private company located in Belfast, Ireland established
in 2005. They have outsourced the production of their ligatures. Since they are private it is difficult to
find full company information especially located in Belfast. One reference I noted stated they were on target to do 2 million in sales a few years after establishment in 2005. Another noted approximately 400,000 Euro
or pounds in cash. They have their Haemoband in multiple countries with at least 15 distributors or more, including Australia, Hong Kong, New Zealand, Europe, U.S. etc. There are multiple medical supply companies offering their product in the U.S. They have made milestone payments to Flexpoint probably to total 100's of thousands after all phases complete. They are in the midst of the clinical trials for the scopes.
They completed trials for their ligature as well and received US FDA clearance in the past. They had
a booth at Medica, the largest European Medical Expo.
They are not Olympus or Flexpoint stock would be 10x. However, they have a track record,
cash in the bank, a successful product with multiple distribution channels which fit perfectly
with the Flexpoint scope i.e. marketing to GI physicians dealing with colon issues.
They have outsourced production and distribution and managed to stay small and probably
have pretty decent sales as noted above. They may be lean, but probably hungry, competent (GI physician part owner and found) and maybe just what the "doctor" ordered. JMO
Veristride using flexpoint sensors in their inserts at the CES. CES product chosen as top
Innovative product. Breaking into the rehab and medical market. It all adds up. Steve did you say you were buying back the 200k shares you sold yesterday? (LOL)
Early profit taking hammered the stock today without full recovery and many, but not all technicals turned negative. Funky low print allowed for gap close. Impatient investors waiting for news, but fundamentals unchanged.
Tomorrow may be a day to watch. See if buyers return?
There was some previous speculation on this thread that they might have been at the CES this year
in association with Veristride (a start-up from University of Utah) with inserts for rehab and medical applications. Albeit speculation. Increased exposure while waiting for very significant developments
While we await some blockbuster news they're keeping us in the loop, hooking up
with retailers, buyers, distributors for the trainers. Not just running, but golf, skiing, football etc.
Looked up their website. They have a big push going on for a start up to use foot metrics as in the trainer to
do rehabilitation. They have a nice marketing presentation. My "guess" is that they are using our sensors
and inserts since we have "the best technology out there." If true it would provide nice validation,
and point to an increasing customer base for our technology. That's my guess.
Bullish triple top breakout above .30 with print at .32. Going back to 2014 and pre 2012. P&F chart.
Suggests some news next week as mentioned previously. Too soon for Harmoband trial completion, too soon for auto so maybe shoes or new project. "Three horses chomping at the bit." I liked that.